A randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar depression

被引：0
|
作者：
Tohen, M. [1 ]
McDonnell, D. P. [2 ]
Case, M. [2 ]
Kanba, S. [3 ]
Ha, K. [4 ]
Fang, Y. [5 ]
Katagiri, H. [6 ]
Gomez, J. C. [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] Kyushu Univ, Fukuoka 812, Japan
[4] Seoul Natl Univ, Seoul, South Korea
[5] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[6] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China
来源：
BIPOLAR DISORDERS | 2011年 / 13卷
关键词：
olanzapine; bipolar depression; placebo;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [21] Quetiapine in bipolar I depression: double-blind, placebo-controlled study
    Macfadden, W
    Calabrese, JR
    Suppes, T
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    BIPOLAR DISORDERS, 2005, 7 : 72 - 73
  • [22] Naltrexone in Bipolar Disorder With Depression A Double-Blind, Placebo-Controlled Study
    Murphy, Beth L.
    Ravichandran, Caitlin
    Babb, Suzann M.
    Cohen, Bruce M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (06) : 749 - 751
  • [23] Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
    Loebel, Antony
    Cucchiaro, Josephine
    Silva, Robert
    Kroger, Hans
    Hsu, Jay
    Sarma, Kaushik
    Sachs, Gary
    AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (02): : 160 - 168
  • [24] Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
    Earley, Willie
    Burgess, Maria Victoria
    Rekeda, Ludmyla
    Dickinson, Regan
    Szatmari, Balazs
    Nemeth, Gyorgy
    McIntyre, Roger S.
    Sachs, Gary S.
    Yatham, Lakshmi N.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06): : 439 - 448
  • [25] Double-blind, placebo-controlled trial of pioglitazone for bipolar depression
    Aftab, Awais
    Kemp, David E.
    Ganocy, Stephen J.
    Schinagle, Martha
    Conroy, Carla
    Brownrigg, Brittany
    D'Arcangelo, Nicole
    Goto, Toyomi
    Woods, Nicole
    Serrano, Mary Beth
    Han, Huiqin
    Calabrese, Joseph R.
    Gao, Keming
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 245 : 957 - 964
  • [26] Light therapy for bipolar depression: a randomized, double-blind, parallel, placebo-controlled trial
    Sit, D.
    McGowan, J.
    Wiltrout, C.
    Diler, R. S.
    Dills, J.
    Luther, J.
    Seltman, H.
    Wisniewski, S.
    Terman, M.
    Wisner, K. L.
    BIPOLAR DISORDERS, 2017, 19 : 60 - 61
  • [27] A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania
    Van Ameringen, Michael
    Mancini, Catherine
    Patterson, Beth
    Bennett, Mark
    Oakman, Jonathan
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (10) : 1336 - 1343
  • [28] A double-blind, placebo-controlled study of olanzapine in adolescents with schizophrenia
    Kryzhanovskaya, L
    Schulz, C
    McDougle, CJ
    Frazier, JA
    Dittmann, R
    Robertson-Plouch, C
    Bauer, T
    Xu, W
    Wang, WV
    Carlson, J
    Tohen, M
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 224S - 224S
  • [29] A double-blind, placebo-controlled study of olanzapine in adolescents with schizophrenia
    Kryzhanovskaya, L
    Schulz, C
    McDougle, CJ
    Frazier, JA
    Shen, J
    Dittman, R
    Robertson-Plouch, C
    Bauer, T
    Xu, W
    Wang, WV
    Carlson, J
    Corya, S
    Tohen, M
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S258 - S259
  • [30] A double-blind, placebo-controlled study of olanzapine in adolescents with schizophrenia
    Kryzhanovskaya, L
    Schulz, C
    McDougle, CJ
    Frazier, JA
    Dittmann, R
    Robertson-Plouch, C
    Bauer, T
    Xu, W
    Wang, WV
    Carlson, J
    Tohen, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 44 - 45
12345